Intestinal Cell News Volume 9.22 | June 16 2023

    0
    8








    2023-06-16 | ICN 9.22


    Intestinal Cell News by STEMCELL Technologies
    Vol. 9.22 – 16 June, 2023
    TOP STORY

    Cutoff Value of IC50 for Drug Sensitivity in Patient-Derived Tumor Organoids in Colorectal Cancer

    The authors established patient-derived tumor organoids and performed a drug test in 277 samples from 242 colorectal cancer patients who received FOLFOX or XELOX chemotherapy.
    [iScience]

    AbstractFull ArticleGraphical Abstract
    He needed a better model system. So he invented a new organoid. Watch James Wells' webinar.
    PUBLICATIONSRanked by the impact factor of the journal

    Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-Mutant Colorectal Cancer

    To identify drugs that could enhance the efficacy of MEK inhibitors, researchers performed unbiased high-throughput screening using colorectal cancer spheroids.
    [Molecular Cancer Therapeutics]

    Abstract

    Melatonin Regulates Cancer Migration and Stemness and Enhances the Anti-Tumor Effect of Cisplatin

    Melatonin inhibited gastric cancer cell migration and soft agar colony formation. Magnetic-activated cell sorting was applied to isolate CD133+ cancer stem cells.
    [Journal Of Cellular And Molecular Medicine]

    Full Article

    Breviscapine Regulates the Proliferation, Migration, Invasion, and Apoptosis of Colorectal Cancer Cells via the PI3K/AKT Pathway

    The cell proliferation capacity of HCT116 and SW480 cells was assessed using the CCK-8 and EdU assays. Cell apoptosis was tested through flow cytometry, and cell migration and invasion were examined using the transwell assay.
    [Scientific Reports]

    Full Article

    The Oncogenic Function of PLAGL2 Is Mediated via ASCL2 and IGF2 and a Wnt-Independent Mechanism in Colorectal Cancer

    Researchers described the common activation of the zinc finger transcription factor and Let-7 target PLAGL2 in colorectal cancer and found that it was a key driver of intestinal epithelial transformation.
    [American Journal Of Physiology-Gastrointestinal And Liver Physiology]

    Abstract

    PFKFB2 Is a Favorable Prognostic Biomarker for Colorectal Cancer by Suppressing Metastasis and Tumor Glycolysis

    PFKFB2 was selected by metabolism polymerase chain reaction array from colorectal cancer cells under alkaline culture medium and acidic culture medium.
    [Journal of Cancer Research and Clinical Oncology]

    Abstract

    Allyl Isothiocyanate Inhibits Cell Migration and Invasion in Human Gastric Cancer AGS Cells via Affecting PI3K/AKT and MAPK Signaling Pathway In Vitro

    Scientists evaluated the impact of allyl isothiocyanate on cell migration and invasion of human gastric cancer AGS cells in vitro.
    [Environmental Toxicology]

    Abstract

    Jun-APOE-LRP1 Axis Promotes Tumor Metastasis in Colorectal Cancer

    Researchers investigated the role of apolipoprotein E (apoE) in colorectal cancer (CRC) metastasis and identified the transcription factor and receptor of apoE involved in regulation of CRC metastasis.
    [Biomolecules & Biomedicine]

    Abstract

    Metformin Induces a Caspase 3-Unrelated Apoptosis in Human Colorectal Cancer Cell Lines HCT116 and SW620

    The antiproliferative effect of metformin was assayed using an MTS reagent and its ability to inhibit colony formation was demonstrated using a clonogenic assay.
    [Cancer Management And Research]

    Full Article

    Ubiquitin-Like Protein FAT10 Promote Colorectal Cancer Progression by Affecting the Ubiquitination of Capn4

    The authors investigated the function and clinical significance of FAT10 protein expression in colorectal cancer (CRC). Over-expression and knockdown experiments of FAT10 were developed to explore their effects on CRC cell migration and proliferation.
    [Digestive Diseases and Sciences]

    Abstract
    Scientific resources to support your stem cell research. Learn More!
    REVIEWS

    Clinical Impact of Exosomes in Colorectal Cancer Metastasis

    Investigators address the colorectal cancer (CRC) and exosome complex associated with cancer development and progression, the impact of exosomes on CRC screening, and also highlight several exosomes with CRC clinical trials, as well as future directions of exosome-based CRC research.
    [ACS Applied Bio Materials]

    AbstractGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Takeda and HUTCHMED Announce Marketing Authorization Application of Fruquintinib for Previously Treated Metastatic Colorectal Cancer Validated by the European Medicines Agency

    Takeda and HUTCHMED Limited announced that the European Medicines Agency has validated and accepted for regulatory review the marketing authorization application for fruquintinib used for the treatment of adult patients with previously treated metastatic colorectal cancer.
    [Takeda]

    Press Release
    FEATURED EVENT

    Advanced Cell and Tissue Biomanufacturing

    June 25 – 30, 2023
    Newry, Maine, United States

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – Innate Lymphoid Cells

    King’s College London – London, England, United Kingdom

    Postdoctoral Fellow – Virology

    University of Pittsburgh – Pittsburgh, Pennsylvania, United States

    Junior Postdoctoral Position – Molecular Oncology

    The University of Lleida – Lleida, Spain

    Postdoctoral Researchers – Molecular & Biophysical Aspects of Skin and Mucosa Barriers

    Malm̦ University РMalm̦, Sweden

    PhD Student – Cancer Research

    Universitätsklinikum Carl Gustav Carus Dresden – Dresden, Germany

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Intestinal Cell News Twitter